Association analysis of HLA-Class II and Class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis

Human Immunology

Volumn 62, Issue 5, 2001, Pages 509-517

  Meddeb Garnaoui, A ^a   Gritli, S ^a   Garbouj, S ^a   Ben Fadhel, M ^a   El Kares, R ^a   Mansour, L ^a   Kaabi, B ^a,c   Chouchane, L ^d   Ben Salah, A ^b   Dellagi, K ^a  

^a Laboratory of Immunology   (Tunisia)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Candidate gene; DNA typing; Genetic susceptibility; HLA; Leishmaniasis; MHC genes; Tumor necrosis factor

Indexed keywords

HEAT SHOCK PROTEIN 70; HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA ANTIGEN CLASS 3; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR13 ANTIGEN; HLA DR2 ANTIGEN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLELISM; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; INFANT; INTRON; LEISHMANIA INFANTUM; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

ANIMALS; CHILD, PRESCHOOL; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LYMPHOTOXIN-ALPHA; MEDITERRANEAN REGION; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035026916     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(01)00237-3     Document Type: Article

References (46)

1. Liew F.Y., O'Donnell C.A. Immunology of Leishmaniasis. Adv Parasitol. 32:1993;161.
2. Blackwell J.M. Genetic susceptibility to leishmanial infections studies in mice and man . Parasitology. 112:1996;S67.
3. Chadli A, Ben Rachid MS, Fhaiel A: Chronique des leishmanioses en Tunisie. Arch Inst Pasteur (Tunis) 45:1, 1968.
4. Bouratbine A, Aoun K, Chahed MK, Ben Ismail R: Données épidémiologiques sur la leishmaniose viscérale infantile en Tunisie en 1993. Med Mal Infect 28:446, 1998.
5. Badaro R., Jones T.C., Carvalho E.M., Sampaio D., Reed S., Barrel A., Teixeira R., Johnson W.D. New perspectives on a subclinical form of visceral leishmaniasis. J Inf Dis. 154:1986;207.
6. Marty P., Le Fichoux Y., Giordana D., Brugnetti A. Leishmanin reaction in the human population of a highly endemic focus of canine leishmaniasis in Alpes-Maritimes, France. Trans Roy Soc Trop Med Hyg. 86:1992;249.
7. Ben Salah A: Epidemiology and modelling of visceral leishmaniasis in Tunisia. Doctor of Philosophy Thesis. Oxford, UK: University of Oxford, 1999.
8. Sacks D.L., Lal S.L., Shrivastava S.N., Blackwell J., Neva F.A. An analysis of T cell responsiveness in Indian Kala-azar. J Immunol. 138:1987;908.
9. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD Jr: Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76:2066, 1985.
10. Jones E.Y. MHC class I and class II structures. Curr Opin Immunol. 9:1997;75.
11. Marsh S.G. Nomenclature for factors of the HLA system, update July/August 1999. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens. 54:1999;531.
12. Hill A.V.S., Allsopp C.E.M., Kwiatkowski D., Anstey N.M., Twamasi P., Rowe P.A., Bennett S., Brewster D., McMichael A.J., Greenwood B.M. Common west African HLA antigens are associated with protection from severe malaria. Nature. 352:1991;595.
13. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., Blackwell J.M. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 182:1995;1259.
14. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 11:1993;403.
15. Blackwell J., Freeman J., Bradley D. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature. 283:1980;72.
16. Roberts L.J., Baldwin T.M., Curtis J.M., Handman E., Foote S.J. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. J Exp Med. 185:1997;1705.
17. Roberts L.J., Baldwin T.M., Speed T.P., Handman E., Foote S.J. Chromosomes X, 9 and the H2 locus interact epistatically to control Leishmania major infection. Eur J Immunol. 29:1999;3047.
18. Petzl-Erler M.L., Belich M.P., Queiroz-Telles F. Association of mucosal leishmaniasis with HLA. Hum Immunol. 32:1991;254.
19. Lara M.L., Layrisse Z., Scorza J.V., Garcia E., Stoikow Z., Granados J., Bias W. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum Immunol. 30:1991;129.
20. Carrol M.C., Katzman P., Alicot B.M., Koller B.M., Ceraghty D.E., Orr H.T., Strominger J.L., Spies T. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA. 84:1987;8535.
21. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 10:1992;411.
22. Wilson A.G., de Vries N., Pociot F., di Giovine F.S., Van der Putte L.B.A., Duff G.W. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA-A1, -B8 and -DR3 alleles. J Exp Med. 177:1993;557.
23. Wilson A.G., di Giovine F.S., Blakemore A.I.F., Duff G.W. Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1:1992;353.
24. Messer G., Spengler U., Jung M.C., Honold G., Blomer K., Pape G.R., Riethmuller G., Weiss E.H. Polymorphic structure of the tumor necrosis factor (TNF) locus an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production . J Exp Med. 173:1991;209.
25. Sargent C.A., Dunham I., Trowsdale J., Campbell R.D. Human major histocompatibility complex contains genes for the major heat shock protein HSP70. Proc Natl Acad Sci USA. 86:1989;1968.
26. Milner C.M., Campbell R.D. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics. 32:1990;242.
27. Milner C.M., Campbell R.D. Polymorphic analysis of the three MHC-linked HSP70 genes. Immunogenetics. 36:1992;357.
28. Pierce S.K., DeNagel D.C., Van Burskirk A.M. A role for heat shock proteins in antigen processing and presentation. Curr Top Microbiol Immunol. 167:1991;83.
29. Grimberg J., Nawoschik S., Belluscio L., Mc Kee R., Turck A., Eisenberg A. A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucl Acid Res. 17:1989;8390.
30. Tiercy JM, Grundschober C, Jeannet M, Mach B: A comprehensive HLA-DRB, -DQB, and -DPB oligotyping procedure by hybridization with sequence-specific oligonucleotide probes. In: Hui KM, Bidwell JL (eds): Handbook of HLA typing techniques. Atlanta, Georgia: CDC Press, 1993.
31. Spielman R.S., Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet. 59:1996;983.
32. Cavalli-Sforza LL, Bodmer WF: The genetics of human populations. San Francisco, CA: WM Freeman and Co., 1971.
33. Schaefer K.U., Kurtzhals J.A.L., Kager P.A., Gachihi G.S., Gramiccia M., Kagai J.M., Sherwood J.A., Muller A.S. Studies on the prevalence of leishmanin skin test positivity in the Baringo District, Rift Valley, Kenya. Am J Trop Med Hyg. 50:1994;78.
34. Faghiri Z., Taheri F. Study of the association of HLA class I antigens with Kala-azar. Hum Hered. 45:1995;258.
35. Singh N., Sundar S., Williams F., Curran M.D., Rastogi A., Agrawal S., Middleton D. Molecular typing of HLA class I and class II antigens in Indian Kala-azar patients. Trop Med Int Health. 2:1997;468.
36. Barral-Netto M., Badaro R., Barral A., Almeida R.P., Santos S.B., Badaro F., Pedral-Sampaio D., et al. Tumor necrosis factor (Cachectin) in human visceral leishmaniasis. J Infect Dis. 163:1991;853.
37. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW: Effects of a TNFα promoter base transition on transcriptional activity. Br J Rheum 33(Suppl.1):89, 1994.
38. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymophism in the human Tumor Necrosis Factor α promoter on transcriptional activation. Proc Natl Acad Sci USA. 94:1997;3195.
39. McGuire W., Hill A.V.S., Allsopp C.E.M., Greenwood B.M., Kwiatkowski D. Variation in the TNFα promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508.
40. Roy S., McGuire W., Mascie-Taylor C.G.N., Saha B., Hazra S.K., Hill A.V.S., Kwiatkowski D. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Inf Dis. 176:1997;530.
41. Blackwell J.M. Tumour necrosis factor alpha and mucocutaneous leishmaniasis. Parasitol Today. 15:1999;73.
42. Blackwell J.M. Tumour necrosis factor alpha and mucocutaneous leishmaniasis Parasitol . Today. 15:1999;73.
43. Blackwell J.M. Genetics of host resistance and susceptibility to intramacrophage pathogens a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern-Brazil . Int J Parasitol. 28:1998;21.
44. Caplen N.J., Patel A., Millward A., Campbell R.D., Ratanachaiyavong S., Wong F.S., Demaine A.G. Complement C4 and heat shock protein 70 (HSP70) genotypes and type I diabetes mellitus. Immunogenetics. 32:1990;427.
45. Pugliese A., Awdeh Z.L., Galluzzo A., Yunis E.J., Alper C.A., Eisenbarth G.S. No independent association between HSP70 gene polymorphism and IDDM. Diabetes. 41:1992;788.
46. Partanen J., Milner C.M., Campbell R.D., Maki M., Lipsanen V., Koskimies S. HLA-linked heat-shock protein 70 (HSP70-2) gene polymorphism and celiac disease. Tissue Antigens. 41:1993;15.